8-K
Current Report
IRONWOOD PHARMACEUTICALS INC Filed Acc 0001104659-18-049656
Agreement ended · Results of operations · Exit or restructuring costs · Impairment
- Item 1.02 Termination of a material definitive agreement
- Item 2.02 Results of operations and financial condition
- Item 2.05 Costs associated with exit or disposal activities
- Item 2.06 Material impairments
From the SEC's structured data for this filing
Loading a18-18309_38k.htm…